A 55-year-old man reported to the office emergently with a chief complaint of blurry vision at distance in both eyes. He explained in a panic that he had woken up early that morning seeing well, then played a game on his cell phone and noticed that, after he stopped, he no longer needed his reading glasses to read.
A 68-year-old African American female presented for an initial comprehensive ocular examination with a chief complaint of intermittent burning of both eyes over the past two years. The patient denied any additional ocular history and reported a medical history of hypertension for which she was properly medicated with lisinopril/hydrochlorothiazide, an angiotensin-converting enzyme (ACE) inhibitor. She denied having allergies of any kind.
As we watch the ramp-up of COVID-19 vaccination, we can marvel at the ingenuity that brought these vital agents to market in under a year. But it also starkly underlines the importance of vaccines as a whole to society. Unfortunately, a decline in routine vaccination was among the unwelcome consequences of the pandemic lockdowns that began in March 2020, which significantly altered health care as we know it. Patient visits for routine and emergency care began to decrease.1 This has resulted in a reduced rate of vaccinations for vaccine-preventable diseases (VPD) across the nation.
You’ve taken the kids for their checkups and scheduled your parents’ doctor visits. You even went along to make sure they understand what was happening.
Nikki Iravani, OD, is always on the lookout for a great marketing tip.
Nine women ODs were honored during the fourth annual Theia Awards of Excellence from Women In Optometry magazine.